← All trials
NCT06061848
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 1, 2023
- Primary completion
- Dec 28, 2030
- Completion date
- Dec 28, 2031
- First posted
- Sep 29, 2023
- Last posted
- Nov 29, 2023
- Enrollment
- 360
- Arms / groups
- 3 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Karolinska InstituteLead sponsor
- Karolinska InstituteOverall official - principal investigator
- Karolinska InstituteSponsor investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.